Matches in SemOpenAlex for { <https://semopenalex.org/work/W1508816429> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W1508816429 endingPage "341" @default.
- W1508816429 startingPage "340" @default.
- W1508816429 abstract "Catheterization and Cardiovascular InterventionsVolume 81, Issue 2 p. 340-341 Peripheral Vascular Disease Pushing the boundaries of renal denervation for resistant hypertension Deepak L. Bhatt MD, MPH, FSCAI, Corresponding Author Deepak L. Bhatt MD, MPH, FSCAI VA Boston Healthcare System, Brigham and Women's Hospital, and Harvard Medical School, Boston, MassachusettsCorrespondence to: Deepak L. Bhatt, MD, MPH, FSCAI, Professor of Medicine, Harvard Medical School, VA Boston Healthcare System, 1400 VFW Parkway, Boston, MA 02132. E-mail: dlbhattmd@post.harvard.eduSearch for more papers by this author Deepak L. Bhatt MD, MPH, FSCAI, Corresponding Author Deepak L. Bhatt MD, MPH, FSCAI VA Boston Healthcare System, Brigham and Women's Hospital, and Harvard Medical School, Boston, MassachusettsCorrespondence to: Deepak L. Bhatt, MD, MPH, FSCAI, Professor of Medicine, Harvard Medical School, VA Boston Healthcare System, 1400 VFW Parkway, Boston, MA 02132. E-mail: dlbhattmd@post.harvard.eduSearch for more papers by this author First published: 19 February 2013 https://doi.org/10.1002/ccd.24785Citations: 1 Conflict of interest: Dr.Bhatt discloses the following relationships—Advisory Board: Medscape Cardiology; Board of Directors: Boston VA Research Institute, Society of Chest Pain Centers; Chair: American Heart Association Get With The Guidelines Science Subcommittee; Honoraria: American College of Cardiology (Editor, Clinical Trials, Cardiosource), Duke Clinical Research Institute (clinical trial steering committees), Slack Publications (Chief Medical Editor, Cardiology Today Intervention), WebMD (CME steering committees); Other: Senior Associate Editor, Journal of Invasive Cardiology; Research Grants: Amarin, AstraZeneca, Bristol-Myers Squibb, Eisai, Ethicon, Medtronic (co-PI of the Symplicity HTN-3 renal denervation trial), Sanofi Aventis, The Medicines Company; Unfunded Research: FlowCo, PLx Pharma, Takeda. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume81, Issue2February 2013Pages 340-341 SCAI Member Sign in RelatedInformation" @default.
- W1508816429 created "2016-06-24" @default.
- W1508816429 creator A5010571732 @default.
- W1508816429 date "2013-02-01" @default.
- W1508816429 modified "2023-09-26" @default.
- W1508816429 title "Pushing the boundaries of renal denervation for resistant hypertension" @default.
- W1508816429 cites W1583834060 @default.
- W1508816429 cites W1700171129 @default.
- W1508816429 cites W1965955566 @default.
- W1508816429 cites W2114127328 @default.
- W1508816429 cites W2154771984 @default.
- W1508816429 doi "https://doi.org/10.1002/ccd.24785" @default.
- W1508816429 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23423926" @default.
- W1508816429 hasPublicationYear "2013" @default.
- W1508816429 type Work @default.
- W1508816429 sameAs 1508816429 @default.
- W1508816429 citedByCount "1" @default.
- W1508816429 countsByYear W15088164292013 @default.
- W1508816429 crossrefType "journal-article" @default.
- W1508816429 hasAuthorship W1508816429A5010571732 @default.
- W1508816429 hasConcept C126322002 @default.
- W1508816429 hasConcept C164705383 @default.
- W1508816429 hasConcept C2776805190 @default.
- W1508816429 hasConcept C3019558611 @default.
- W1508816429 hasConcept C71924100 @default.
- W1508816429 hasConcept C84393581 @default.
- W1508816429 hasConceptScore W1508816429C126322002 @default.
- W1508816429 hasConceptScore W1508816429C164705383 @default.
- W1508816429 hasConceptScore W1508816429C2776805190 @default.
- W1508816429 hasConceptScore W1508816429C3019558611 @default.
- W1508816429 hasConceptScore W1508816429C71924100 @default.
- W1508816429 hasConceptScore W1508816429C84393581 @default.
- W1508816429 hasIssue "2" @default.
- W1508816429 hasLocation W15088164291 @default.
- W1508816429 hasLocation W15088164292 @default.
- W1508816429 hasOpenAccess W1508816429 @default.
- W1508816429 hasPrimaryLocation W15088164291 @default.
- W1508816429 hasRelatedWork W179724743 @default.
- W1508816429 hasRelatedWork W1996790832 @default.
- W1508816429 hasRelatedWork W2005155794 @default.
- W1508816429 hasRelatedWork W2027424501 @default.
- W1508816429 hasRelatedWork W2046676081 @default.
- W1508816429 hasRelatedWork W2069436293 @default.
- W1508816429 hasRelatedWork W2084728943 @default.
- W1508816429 hasRelatedWork W2085424798 @default.
- W1508816429 hasRelatedWork W2116668464 @default.
- W1508816429 hasRelatedWork W2160555178 @default.
- W1508816429 hasRelatedWork W225971857 @default.
- W1508816429 hasRelatedWork W2337987669 @default.
- W1508816429 hasRelatedWork W2340439717 @default.
- W1508816429 hasRelatedWork W2410303429 @default.
- W1508816429 hasRelatedWork W2411427028 @default.
- W1508816429 hasRelatedWork W2471768720 @default.
- W1508816429 hasRelatedWork W247797332 @default.
- W1508816429 hasRelatedWork W2603898925 @default.
- W1508816429 hasRelatedWork W2728237036 @default.
- W1508816429 hasRelatedWork W3208700212 @default.
- W1508816429 hasVolume "81" @default.
- W1508816429 isParatext "false" @default.
- W1508816429 isRetracted "false" @default.
- W1508816429 magId "1508816429" @default.
- W1508816429 workType "article" @default.